欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号DE/H/7886/001
药品名称Amphotericin B liposomal Tillomed 50 mg Powder for dispersion for infusion
活性成分
    • Amphotericin B 50.0 mg
剂型Powder for dispersion for infusion
上市许可持有人Tillomed Pharma GmbH Mittelstrasse 5/5a 12529 Schonefeld Germany
参考成员国 - 产品名称Germany (DE)
Amphotericin B liposomal Tillomed 50 mg Pulver zur Herstellung einer Infusionsdispersion
互认成员国 - 产品名称
    • Czechia (CZ)
      Amfotericin B liposomal Tillomed 50 mg prášek pro přípravu infuzní disperze
    • Romania (RO)
      Amfotericină B lipozomală Tillomed 50 mg pulbere pentru dispersie pentru perfuzie
    • Slovakia (SK)
    • Croatia (HR)
    • Spain (ES)
    • Portugal (PT)
    • Poland (PL)
    • Latvia (LV)
    • Lithuania (LT)
      Amphotericin B liposomal Tillomed 50 mg milteliai infuzinės dispersijos koncentratui
    • Estonia (EE)
    • Hungary (HU)
      Amfotericin B liposomal Tillomed 50 mg por infúzióhoz való diszperzióhoz
    • Bulgaria (BG)
      Amphotericin B liposomal Tillomed
许可日期2025/04/09
最近更新日期2025/04/17
药物ATC编码
    • J02AA01 amphotericin B
申请类型
  • TypeLevel1:Known Active Substance
  • TypeLevel2:Initial Application
  • TypeLevel3:Hybrid application (Art 10.3 Dir 2001/83/EC)
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase